Roxadustat treatment for anemia in peritoneal dialysis patients: A randomized controlled trial.
Sign Up to like & getrecommendations! Published in 2021 at "Journal of the Formosan Medical Association = Taiwan yi zhi"
DOI: 10.1016/j.jfma.2021.06.004
Abstract: BACKGROUND/PURPOSE Roxadustat, a first-in-class hypoxia-inducible factor prolyl hydroxylase inhibitor, promotes erythropoiesis and regulates iron metabolism. This study investigated the efficacy and safety of roxadustat in Chinese patients with anemia on peritoneal dialysis (PD). METHODS One… read more here.
Keywords: week; trial; anemia peritoneal; treatment ... See more keywords